Document:

exv4wxcyx10y

 

Exhibit 4(c)(10)

CONFIDENTIAL

CONSULTING AGREEMENT

     This Consulting Agreement (the “Agreement”) is made by and between Dennis J. Selkoe, M.D.
(“Consultant”), an individual with an address of Center for Neurologic Diseases, Harvard Medical
School, Brigham and Women’s Hospital, 77 Avenue Louis Pasteur, HIM 730, Boston, MA 02115, and
Elan Pharmaceuticals, Inc., a Delaware corporation with an address of 800 Gateway Boulevard, South
San Francisco, California 94080 (“Elan”), and is effective as of July 1, 2006 (“Effective Date”).

RECITALS

     A. Consultant possesses special expertise and knowledge within the field of research and
clinical practice relating to various diseases (“Consultant Field”);

     B. Elan has need for Consultant’s services with respect to the treatment and/or prevention of
neurodegenerative disease and autoimmune disease (“Elan Field”);

     C. Elan and certain of its Affiliates (as defined below), on the one hand, and Consultant and,
in certain cases, certain other parties, on the other hand, have previously entered into various
consulting and related agreements, including, without limitation, (i) the Consulting Agreement,
dated as of July 1, 1986, between Athena Neurosciences, Inc., a Delaware corporation (“Athena”),
and Consultant; (ii) the Consultant Proprietary Information and Inventions Agreement, dated as of
October 30, 1986, by and between Athena Delaware, Inc., a Delaware corporation, and Consultant;
(iii) the Amendment to Consulting Agreement, dated as of June 5, 1987, by and between Athena and
Consultant; (iv) the Material Transfer Agreement, dated as of October 1, 1986, by and among Athena,
Eli Lilly and Company, Consultant, Howard L. Weiner and Brigham and Women’s Hospital; (v) the
Consulting Agreement Scientific Advisory Committee, dated as of November 7, 1996, by and between
Elan Corporation, plc and Consultant; (vi) the Confidentiality and Material Transfer Agreement,
dated as of May 30, 2001, by and among Elan, Consultant and The Brigham and Women’s Hospital, Inc.;
(vii) the Transfer of Materials Approval Form, dated as of June 3, 2001, by and between Elan and
Consultant; (viii) the Consulting Agreement, dated as of April 1, 2002, by and between Consultant
and Elan; (ix) the Material Transfer Agreement, dated as of June 25, 2002, by and among Elan,
Consultant and Mr. Malcolm Lessing; and (x) the Consulting Agreement, dated as of May 20, 2004, by
and between Consultant and Elan (collectively, the “Previous Agreements”); and

     D. Elan and Consultant now desire to enter into this Agreement whereby Consultant shall
perform consulting services for Elan on the terms and conditions set forth below.

 - 1- 

 

CONFIDENTIAL

AGREEMENT

          NOW, THEREFORE, Consultant and Elan agree as follows:

          1. Description of Services. Subject to the terms and conditions of this Agreement,
Consultant shall perform services for Elan, according to the time frame agreed upon by the parties,
with respect to the Elan Field, limited to advising and/or speaking at various Elan Committee
meetings, providing review of and advice on the merit or value of Elan’s research and development
concerning Elan Field, as well as information on new developments and opportunities in
neurodegenerative disease and, autoimmune disease (the “Services”). Services shall not (i)
involve any use of the facilities, space, materials or other resources of The Brigham and Women’s
Hospital, Inc. d/b/a Brigham and Women’s Hospital (“Hospital”), including resources provided
in-kind by outside sources (provided that use alone by the Consultant of the Consultant’s office
space and word processor shall not be considered a prohibited use of such Hospital resources), or
(ii) use direct or indirect financial support from Hospital, including funding from any outside
source awarded to or administered by Hospital. In the event that the Services overlap with a field
in which the Consultant is performing research at Hospital sponsored by a third party for-profit
entity, this Agreement will not be effective with respect to such overlapping services unless and
until it is approved by the Hospital Office of Corporate Sponsored Research and Licensing (“CSRL”)
in consultation with such third party. Consultant shall spend no more than twenty (20) days
(excluding week-ends and holidays) in performing Services for Elan. As used in each instance in
this Agreement, the term “Services” shall mean the Services as defined and expressly limited in
this Section 1.

          2. Term and Renewal. This Agreement shall be effective as of the Effective Date and
shall remain in effect for a period of three (3) years unless terminated pursuant to this
Agreement. This Agreement may only be renewed for additional periods on terms mutually agreed upon
in writing by the parties. Neither party shall have any obligation to renew this Agreement.

          3. Fees and Expenses.

          (a) In return for services actually rendered, Elan will pay Consultant at a rate of $12,500.00
per quarter.

          (b) Elan shall also reimburse Consultant for all out-of-pocket expenses actually incurred by
Consultant in rendering Services under this Agreement so long as such expenses, in Elan’s opinion,
are reasonable and necessary. Such expenses will include reasonable and necessary travel lodging
and meals. Consultant shall provide Elan with a written expense report, complete with receipts or
other reasonable documentation, for all such expenses requested for reimbursement.

          4. Invoices. Amounts due hereunder shall be payable no later than thirty (30) days
from Elan’s receipt of a written invoice with an expense report and accompanying supporting
documentation therefor.

 - 2- 

 

CONFIDENTIAL

          5. Confidentiality; Proprietary Information; Intellectual Property.

          (a) Any and all information which Elan or its Affiliates have previously disclosed to
Consultant under any Previous Agreement or may disclose to Consultant under this Agreement, in all
cases, will be considered confidential, including, but not limited to, information related to the
Elan Field. “Affiliate” shall mean any corporation or other entity that controls, is controlled
by, or is under common control with, a party hereto. An entity shall be regarded as in control of
another corporation or entity if it owns or directly or indirectly controls more than 50% of the
voting securities or other ownership interest of the other corporation or entity or otherwise has
the power to direct or control the management or operations of the other corporation or entity,
whether by contract or otherwise.

          (b) Consultant further agrees that all discussions and negotiations with respect to this
Agreement are confidential except that same may be disclosed to Hospital and its employees and
legal representatives under an appropriate confidentiality agreement.

          (c) Consultant understands that Elan possesses and will continue to possess information that
has been created, discovered or developed, or has otherwise become known to Elan or its Affiliates
and/or in which property rights have been assigned or otherwise conveyed to Elan or its Affiliates,
which information has commercial value in the business in which Elan is engaged. All such
information, including the information described in Sections 5 (a) and (b) above, and including any
other information developed by or on behalf of Consultant in and during the performance of the
Services pursuant to this Agreement or any Previous Agreement, is hereinafter referred to as
“Proprietary Information.” By way of illustration, but not limitation, Proprietary Information
includes trade secrets, processes, formulae, data and know-how, improvements, inventions,
techniques, marketing plans, strategies, forecasts and customer and contact lists. Accordingly,
Consultant further agrees as follows:

     (i) All Proprietary Information shall be the sole property of Elan or its Affiliates
and their assigns, as the case may be, and such parties shall be the sole owners of all
patents and other rights in connection therewith. At all times during this Agreement and
for a period of five (5) years after expiration or termination of this Agreement, Consultant
will keep in confidence and trust all Proprietary Information, and will not use or disclose
any Proprietary Information without the prior written consent of Elan, except as may be
necessary in the ordinary course of performing the Services of Consultant hereunder. No
announcement, oral presentation or publication of any kind relating to any Proprietary
Information shall be made by Consultant without the prior written consent of Elan; and

     (ii) All documents, data, records, apparatus, equipment and other physical property,
whether or not pertaining to Proprietary Information, furnished to Consultant by or on
behalf of Elan in the performance of the Services or created by or on behalf of Consultant
in and during the performance of the Services pursuant to this Agreement or any Previous
Agreement, shall be and remain the sole property of Elan and/or its Affiliates and shall be
returned promptly as and when requested by Elan. Should Elan not so request, Consultant
agrees to return and deliver all such property upon expiration or termination of this
Agreement for any reason and Consultant shall not retain or

 - 3- 

 

CONFIDENTIAL

reproduce any such property upon expiration or termination, except that Consultant may
keep one (1) copy thereof for the purpose of complying with the terms of this Agreement.

Notwithstanding the foregoing, Proprietary Information shall not be deemed to include information
that Consultant can demonstrate (a) is or hereafter becomes generally available to the public other
than as a result of a breach of this Agreement or any Previous Agreement by Consultant, (b) was
made known to Consultant by a third party lawfully in possession of such information (as evidenced
by Consultant’s written records) without breach of any obligation of confidentiality or duty, or
(c) is required to be disclosed pursuant to a governmental or court proceeding, provided that
Consultant notifies Elan in writing in a timely manner of the required disclosure such that Elan
has an opportunity to seek a protective order to limit the nature and scope of the information to
be disclosed, and this exception only permits disclosure to the extent and to the persons, as
required by such governmental or court proceeding.

     (d) Consultant further agrees as follows:

     (i) Consultant shall promptly disclose to Elan or its designee all intellectual
property (including, but not limited to any inventions, improvements, formulae, processes,
techniques, know-how, data, patents or applications for patents, trade secrets, trademarks,
copyrights and confidential information as described in this Section 5), which: (A) is
created by Consultant specifically for Elan in and during the performance of the Services
hereunder or under any Previous Agreement; or (B) results from the use of property or
premises owned, leased or contracted for, by or on behalf of Elan or its Affiliates
(collectively, “Intellectual Property”).

     (ii) Consultant agrees to and does hereby sell, assign, transfer and set over to Elan,
its Affiliates, successors or assigns, as the case may be, all right, title and interest in
and to all Intellectual Property created individually or in conjunction with others in
performance of this Agreement or any Previous Agreement, to be held and enjoyed by Elan, its
Affiliates, successors or assigns, as the case may be, to the full extent of the term for
which any patents may be granted and as fully as the intellectual property would have been
held by Consultant had this Agreement, sale or assignment not been made.

     (iii) Consultant shall execute and deliver any and all instruments and documents and
perform any and all acts, necessary to obtain, maintain or enforce patents, trademarks,
trade secrets and copyrights for such Intellectual Property, and shall make, execute and
deliver any and all instruments and documents and perform any and all acts necessary to
obtain, maintain or enforce patents, trademarks, trade secrets and copyrights for such
Intellectual Property as Elan may designate in any and all countries. All costs and
expenses of application and prosecution of such patents, trademarks, trade secrets and
copyrights shall be paid by Elan.

     (iv) Any copyrightable material prepared by Consultant specifically for Elan in the
performance of the Services under this Agreement or any Previous Agreement, are prepared as
works for hire for the benefit of Elan. Consultant hereby assigns to Elan any copyright to
which Consultant is entitled for any copyrightable material prepared specifically for Elan
in the performance of the Services under this Agreement or any Previous Agreement. Elan
shall have the right to reproduce, modify and use, for any

 - 4- 

 

CONFIDENTIAL

purpose related to its lawful business, such material and all results which were
generated by Consultant specifically for Elan in the performance of Services under this
Agreement or any Previous Agreement.

     (v) Upon the written request of Elan, Consultant shall make any assignment provided for
in this Section 5 directly to, or for the benefit of, an Elan Affiliate or Elan’s designee,
including Consultant’s performance of any related obligations hereunder.

          (e) Notwithstanding anything to the contrary in this Agreement, in accordance with Hospital’s
Intellectual Property Policy, and subject to the next succeeding paragraph, Elan shall not through
this Agreement obtain any right in or respecting any invention the conception or reduction to
practice of which: (i) received direct or indirect financial support from Hospital, including
funding from any outside source awarded to or administered by Hospital, or (ii) made use of any
space, facilities, materials or other resources of Hospital including resources provided in-kind by
outside sources. In accordance with the Hospital’s Intellectual Property Policy, Consultant shall
disclose to CSRL, in confidence, all inventions which are related to Consultant’s research,
clinical, or educational activities at Hospital in order to provide Hospital an opportunity to
assess, together with Elan, whether the invention is subject to the provisions of this paragraph.

          All inventions hereunder which relate to any separate research agreement shall be deemed to be
inventions under such research agreement and Elan’s, Hospital’s and Consultant’s rights and
obligations with respect to said inventions shall be governed solely by the terms of such research
agreement and not by the terms of this Agreement.

          6. Remedies. (a) Consultant acknowledges that Elan will have no adequate remedy at
law if Consultant breaches the terms of Section 5 hereof. Accordingly, in such event, Elan shall
have the right, in addition to any other rights it may have at law or equity, to obtain in any
tribunal of competent jurisdiction injunctive relief to restrain any breach or threatened breach.
(b) If, due to reasons within Consultant’s reasonable control, Consultant’s Services fail to meet
standards generally accepted in the applicable industry, or if Consultant fails to provide
agreed-upon Services in a timely manner, Elan shall have the right, in addition to any other remedy
it may have at law or equity, to: (i) terminate this Agreement immediately upon written notice to
Consultant; (ii) require that defective Services be replaced or remedied, as the case may be,
without charge to Elan; and (iii) correct, or have corrected by a third party, the defective
Services and withhold from amounts owing to Consultant hereunder all amounts incurred by Elan in
taking such corrective measures.

          7. Contacts at Elan. In connection with Consultant’s performance of Services under
this Agreement, Consultant shall deal exclusively with Dr. Ted Yednock, Dr. Dale Schenk, Dr. Lars
Ekman or such other person or persons as Elan may designate in writing as Consultant’s contact for
purposes of this Agreement (Dr. Yednock, Dr. Schenk, Dr. Ekman and each such designated person
being hereinafter referred to as a “Designated Contact”). All visits by Consultant to the premises
of Elan or any of its Affiliates in connection with Consultant’s performance of Services under this
Agreement shall be coordinated and scheduled through a Designated Contact. All requests for
documents or information and all

 - 5- 

 

CONFIDENTIAL

communications with personnel of Elan or any of its Affiliates in connection with Consultant’s
performance of Services under this Agreement shall be coordinated and arranged through a Designated
Contact. It is understood by the parties hereto that the foregoing provisions of this Section 7
shall not affect Consultant’s right to attend meetings of the Board of Directors of Elan on the
premises of Elan or any of its Affiliates in his capacity as a director of Elan, and also shall not
affect Consultant’s right to obtain documents and information provided to him in his capacity as a
director of Elan or to request documents and information in his capacity as a director of Elan.
Any such requests by Consultant for documents and information in his capacity as a director of Elan
shall be directed to the Company Secretary of Elan.

          8. Termination. This Agreement may be terminated by either party with or without
cause upon thirty (30) days prior written notice.

          In the event this Agreement is terminated pursuant to this Section prior to completion of the
Services, Consultant shall cease work upon Elan’s request, and shall be entitled to receive its fee
for work actually and reasonably performed through the effective date of termination.

          The provisions of Sections 5 (for a period of five (5) years), 6, and 10-16, inclusive, shall
survive expiration or termination of this Agreement.

          9. Independent Contractor. Nothing in this Agreement shall be construed to create an
employment relationship between Consultant and Elan. Consultant shall be an independent contractor
and shall have no authority to enter into contracts on behalf of Elan, bind Elan to any third
parties or act as an agent on behalf of Elan in any way. Consultant shall not be entitled to
receive any compensation, or medical or other benefits as an Elan employee. Accordingly,
Consultant shall account for and report, and be liable for the payment of all applicable federal
and state income taxes, social security taxes, and all other taxes due on payments received by
Consultant hereunder. Consultant hereby acknowledges that Elan will report as compensation all
payments to Consultant hereunder.

          10. Consultant’s Representations and Warranties. Consultant hereby represents and
warrants to Elan that (a) Consultant has the authority to enter into and perform this Agreement,
and (b) performance of Consultant’s Services as contemplated by this Agreement will not result in
the breach or violation of any contract, arrangement or understanding (including without limitation
any intellectual property rights or any agreement of confidentiality or non-disclosure, whether
written or oral) which Consultant may have with any third party (including without limitation
current and former employers of Consultant and any other companies or persons for which Consultant
has performed or is performing consulting services), and (c) Consultant is not in breach of any
Previous Agreement. ). Notwithstanding anything to the contrary in this Agreement, nothing in this
Agreement shall be construed to restrict or limit the duties Consultant is performing or may
perform in the course of, or incidental to, Consultant’s appointment at Hospital, including but not
limited to research sponsored by a third party commercial entity, nor shall anything in this
Agreement be construed to restrict or limit Consultant’s right to serve as an advisor to any
hospital, or to any governmental or not-for-profit organization provided that no Proprietary
Information of Elan is used.

 - 6- 

 

CONFIDENTIAL

          11. Compliance Standards. During the term of this Agreement and any renewal term,
Consultant shall comply with all applicable laws, rules and regulations in the conduct of the
Services being performed.

          12. Severability. If any provision of this Agreement is declared void or
unenforceable, such provision shall be deemed modified to the extent necessary to allow
enforcement, and all other portions of this Agreement shall remain in full force and effect.

          13. Entire Agreement, Amendments. This Agreement contains the entire and complete
agreement between the parties with respect to the subject matter hereof, and supersedes all prior
oral and/or written agreements with respect to the subject matter hereof, and all Previous
Agreements, other than, in each case, any currently effective confidentiality, disclosure or
assignment obligation. Any changes to this Agreement must be in writing and signed by both
parties.

          14. Successors. This Agreement shall be binding upon and inure to the benefit of the
successors, assigns and legal representatives of the parties.

          15. Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of California without regard to its conflicts of laws provisions and the
parties agree to personal jurisdiction and venue in the state and federal courts of San Francisco,
California, in any suit or proceeding arising out of the subject matter of this Agreement.

          16. Use of Name; No Liability; Indemnification. Elan may use the Consultant’s name
and in so doing may cite the Consultant’s relationship with Hospital, so long as any such usage (i)
is limited to reporting factual events or occurrences only, and (ii) is made in a manner that could
not reasonably constitute an endorsement of Elan or of any Elan program, product or service.
However, Elan shall not use the Consultant’s name, Hospital’s name, or the name of Partners
HealthCare System, Inc. in any press release, or quote the consultant in any company materials, or
otherwise use the Consultant’s name, Hospital’s name, or the name of Partners HealthCare System,
Inc. in a manner not specifically permitted by the preceding sentence, unless in each case Elan
obtains in advance the written consent of Hospital and/or Partners HealthCare System, Inc., and, in
the case of the use of the Consultant’s name, the Consultant’s consent as well. Each of Elan and
Consultant acknowledges and agrees that (i) Consultant is entering into this Agreement in his
individual capacity and not as an employee or agent of Hospital, and (ii) Hospital is not a party
to this Agreement and has no liability or obligation whatsoever hereunder. Elan shall indemnify,
defend and hold harmless Consultant and Consultant’s successors, heirs and assigns and Hospital and
its trustees, employees and staff and their respective successors, heirs and assigns
(“Indemnitees”) against any liability, damage, loss or expense (including reasonable attorneys’
fees and expenses of litigation) incurred by or imposed upon the Indemnitees or any one of them in
connection with any claims, suits, actions, demands or judgments arising from the good faith
performance of the Services by Consultant.

          17. Execution in Counterparts or by Facsimile. This Agreement may be executed in one
or more counterparts, each of which shall be deemed an original but
all of which

 - 7- 

 

CONFIDENTIAL

together shall constitute one and the same document. This Agreement may be executed by
facsimile. The parties agree that facsimile copies of signatures have the same effect as original
signatures.

          DATED as of the Effective Date, and executed by:

	 	 	 	 	 	 	 	 	 
	ELAN
PHARMACEUTICALS, INC.	 	DENNIS J. SELKOE, M.D.	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Richard T. Collier
 

	 	 
	 	/s/ Dennis J. Selkoe, M.D.
 

	 	 
	Name:

	 	Richard T. Collier	 	 	 	 	 	 
	Title:

	 	Director, Vice President, Secretary	 	 	 	 	 	 

 - 8-exv4wxcyx14y

 

Exhibit 4(c)(14)

ELAN CORPORATION, plc

CASH BONUS PLAN

Effective January 1, 2006 And

Revised as of May 22, 2006

INTRODUCTION AND PURPOSE

The Elan Corporation, plc Cash Bonus Plan has been established to financially reward employees if
and when the Company achieves its strategic and operating goals. Cash Bonus Plan financial rewards
will be based on a combination of individual, team, group and company performance measurements.
This Cash Bonus Plan has also been established to provide an incentive for employees to remain in
employment at Elan through (and beyond) the date of payout of any cash bonus (as set forth below).

ELIGIBILITY TO PARTICIPATE IN THE PLAN

Full-time and part-time employees who are not participating in a formal Elan sales or incentive
plan are eligible to participate in the Cash Bonus Plan. At the Company’s discretion, employees
who are participating in a formal Elan sales or incentive plan may also be considered for a Cash
Bonus Plan award.

The Cash Bonus Plan is operated on a calendar year basis (January 1 through December 31).
Employees employed by the Company on January 1 of the plan year will be eligible for full
participation in the plan. Employees hired after January 1 (but prior to October 1) will be
eligible to participate in the plan on a pro-rated basis, based on the date of hire. Employees
hired on or after October 1 of the plan year will not be eligible to participate in the plan in
that year. In addition, a condition to earning the award is that an employee remains employed
through the pay date of the award, which will be not later than March 15 in the year following the
conclusion of the plan year. An employee who leaves employment prior to the pay date of the award
will not have earned any bonus.

Change in Status During the Plan Period

	1.	 	Band Change: Employees’ annual target bonus amounts are linked in part to their band
levels in Elan’s Total Compensation program, and band-level targets help determine the overall
annual cash bonus pool. If employees change band levels during the course of the plan year,
the impact of their different band levels on any recommended Cash Bonus Plan award will be
considered proportionally to the time spent in each band.

	2.	 	Termination: Consistent with the eligibility rules, employees who terminate for any
reason prior to the pay date of the award will not be eligible for any award associated with
work performed during the preceding plan period.

	3.	 	Promotion to a Position Included in a Formal Sales or Incentive Plan: If an employee
assumes a position wherein they will participate in a formal Elan sales or incentive

1

 

plan,
they may, at the Company’s discretion, be considered for a pro-rated Cash Bonus Plan award
relative to their service before assuming a non-eligible position.

	4.	 	Disability, Retirement, Leave of Absence: An employee whose status as an active
employee is changed during the plan period due to disability, retirement or leave of absence
may be considered for a prorated award.

	5.	 	Death: An employee whose status as an active employee is changed during the
plan period due to death may be considered for a full year award.

CASH BONUS POOL

Cash Bonus Awards are funded from an annual cash bonus pool. The size of the cash bonus pool is
influenced by a number of factors, including band-level targets and the company’s performance,
strategy and priorities.

AWARDS

Employees’ Cash Bonus Plan awards are generally expressed as a percentage of their annual,
regular-salary earnings. For the purposes of this Plan, annual, regular-salary earnings shall
equal an employee’s base salary earned during the plan year. Shift differential and overtime will
also be included in annual, regular-salary earnings as applicable per location regulations.

Any bonus awards under the plan shall be made on or before March 15 in the year following the
conclusion of the plan year. Payments under the plan are subject to the normal withholding of
taxes as required by governing country and local regulations. For U.S.-based employees, payments
will not be considered in the calculation of benefits, with the exception of the Elan 401(k) Plan,
from which participating employees’ elected contribution percentage will be applied.

PERFORMANCE MEASUREMENTS

Cash Bonus Plan rewards will be based on a combination of individual, team, group and company
performance measurements and are determined at the sole discretion of the Company.

Company Performance Measurements

Elan measures its performance against a broad series of financial, operational and scientific
objectives and accomplishments and sets annual metrics relating to them.

Employee Performance Measurements

Each employee will work with their manager to establish objectives that support the overall company
objectives. At the conclusion of the plan year, the employee’s performance against the individual
objectives will be evaluated.

2

 

Discretion and Differentiation

During the company’s annual performance management process, employees’ performances are assessed
relative to their individual and, when appropriate, team or group goals, all of which should align
with the company’s goals. Based on these assessments and a commitment to foster a differentiated
pay-for-performance culture, Elan senior management prepares initial Cash Bonus Award
recommendations for all employees eligible to participate in the plan.

At the conclusion of the plan year, the Leadership Development and Compensation Committee (LDCC) of
the Board of Directors, at its discretion and as part of its responsibilities, reviews the
company’s performance and determines the cash bonus pool for the plan year.

After the LDCC determines the funding of the cash bonus pool, the company’s executive management
team, led by the CEO, reconciles the cash bonus pool with the initial Cash Bonus Award
recommendations prepared by senior management.

Ultimately, any payouts of the Cash Bonus Plan are based on assessments of the company’s
performance as reflected by the LDCC’s funding of the cash bonus pool; individual performances as
reflected by the company’s performance management processes; and the Company’s strategy and
priorities. Each of these assessments is determined solely within the discretion of the Company.

PLAN PROVISIONS

Eligibility for participation in this plan does not guarantee employment, nor does participation at
one time guarantee ongoing participation, nor is their any guarantee that any plan metrics or
guidelines for one plan year will carry automatically to another plan year. Final participant
awards are subject to the approval of the CEO and the Leadership Development and Compensation
Committee (LDCC).

Participation in this plan should in no way be construed as a contract or promise of employment
and/or compensation. Employment is at will (depending upon location) and, therefore, employment
can terminate, with or without cause and with or without notice, at any time at the option of the
Company or employee.

The Company reserves the rights to adjust, amend, suspend, terminate or make exceptions to this
plan at any time.
The plan is administered by Elan Strategic Human Resources/Global Compensation, to whom any
questions should be addressed.

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}]]